eyeforpharma is now Reuters Events - LEARN MORE
3 Questions to Joel Beetsch, Vice President of Patient Advocacy, Celgene
eyeforpharma asked Joel Beetsch, Vice President of Patient Advocacy at Celgene, 3 questions about how patient centricity is changing the landscape of clinical trials.
Joel will recently spoke at eyeforpharma's Patient-Centered Clinical Trials Conference on 4-5th September in Boston.
Question 1: What is the source of your personal inspiration in improving patient engagement in your work?
Since you're here...
... and value our content, you should sign-up to our newsletter. Sign up here